Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Ovid Therapeutics Inc (OVID)

Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting GlobeNewswire - Mon Dec 2, 7:00AM CST

OVID : 0.9991 (-2.05%)
Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 12, 7:00AM CST

OVID : 0.9991 (-2.05%)
Ovid Therapeutics to Host Investor Event GlobeNewswire - Thu Oct 31, 7:00AM CDT

OVID : 0.9991 (-2.05%)
Buy, Sell - Buy enter button by Ardasavasciogullari via iStock
3 'Strong Buy'-Rated Stocks to Buy Now on the Dip Barchart - Wed Jul 31, 6:30AM CDT

These outstanding growth stocks are worth buying on the dip.

AMZN : 224.92 (+0.73%)
$SPX : 5,930.85 (+1.09%)
GEHC : 78.91 (+1.91%)
GD : 263.64 (+1.29%)
OVID : 0.9991 (-2.05%)
TAK : 13.10 (+0.69%)
Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights Globe Newswire - Tue Aug 9, 2022

Anticipates filing an Investigational New Drug application for OV329, a potent GABA-aminotransferase inhibitor, and initiating a Phase 1 trial in the...

OVID : 0.9991 (-2.05%)
Ovid Therapeutics Presents Preclinical Data on OV329 at the Epilepsy Foundation Pipeline Conference Globe Newswire - Mon Jun 6, 2022

OV329 demonstrated robust anti-seizure activity in multiple preclinical seizure and epilepsy models, including treatment-resistant seizuresData demonstrate...

OVID : 0.9991 (-2.05%)
Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights Globe Newswire - Tue May 10, 2022

Ovid anticipates filing an investigational new drug application (IND) for OV329, a potent GABA aminotransferase inhibitor, and initiating Phase 1 trials in...

OVID : 0.9991 (-2.05%)
Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference Globe Newswire - Fri Apr 8, 2022

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that...

OVID : 0.9991 (-2.05%)
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results Globe Newswire - Tue Mar 15, 2022

Ovid executing on its strategy to build a leading epilepsy pipelineOV329 expected to enter the clinic in 2022Organization reshaped to reduce personnel by...

OVID : 0.9991 (-2.05%)
Ovid Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference Globe Newswire - Fri Mar 4, 2022

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that...

OVID : 0.9991 (-2.05%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot